
Breathomix is a leader in eNose technology and breath analysis, developing the non-invasive BreathBase® Solution for early disease detection and precision medicine. Their mission is to make breath analysis as routine in clinical practice as blood testing, envisioning a future where it's accessible from hospitals to homes. The BreathBase® Solution comprises the SpiroNose®, a clinically validated eNose device for high-precision, real-time breath analysis, and the BreathBase® Platform, which processes breath measurements to generate and validate diagnostic models. They also maintain the world's largest dynamic database of exhaled breath profiles and clinical data. The company focuses on areas such as cancer, inflammatory, and infectious diseases, aiming to transform patient care through accessible breath diagnostics.

Breathomix is a leader in eNose technology and breath analysis, developing the non-invasive BreathBase® Solution for early disease detection and precision medicine. Their mission is to make breath analysis as routine in clinical practice as blood testing, envisioning a future where it's accessible from hospitals to homes. The BreathBase® Solution comprises the SpiroNose®, a clinically validated eNose device for high-precision, real-time breath analysis, and the BreathBase® Platform, which processes breath measurements to generate and validate diagnostic models. They also maintain the world's largest dynamic database of exhaled breath profiles and clinical data. The company focuses on areas such as cancer, inflammatory, and infectious diseases, aiming to transform patient care through accessible breath diagnostics.